Organization to Achieve Solutions in Substance Abuse Report issue

Foundation Phase 2 Phase 4
Founded: Oakland CA United States (1998)

Organization Overview

First Clinical Trial
2003
NCT00249574
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

OASIS Clinic | Organization to Achieve Solutions in Substance Abuse (OASIS)

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (2 trials)

Drugs in Phase 2 Trials (4)

emtricitabine (emtriva) (1 trial)

lopinavir (Kaletra) (1 trial)

ritonavir (Norvir) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Other Trials (2)

interferon alpha-2b (Intron-A) (1 trial)

naloxone (narcan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 7